{"id":1452639,"title":"DSEN Abstract: Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-05-02","captureTimestamp":"2026-05-02T04:42:54.806000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52727.html","snippet":"DSEN Abstract Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia In the treatment of chronic hepatitis C, ribavirin is often incorporated to improve treatment effectiveness. However, 1 in 3 treated patients develop severe anemia. This study…","rawSnapshotUrl":"/api/snapshots/raw/1452639","browseUrl":"https://replay.healtharchive.ca/job-8/20260502044254/https://cihr-irsc.gc.ca/e/52727.html#ha_snapshot=1452639","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}